Cargando…
FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells
BACKGROUND: The immunophilin FKBP12 binds to TGF-β family type I receptors, including the BMP type I receptor ALK2. FKBP12 keeps the type I receptor in an inactive state and controls signaling activity. Removal of FKBP12 with drugs such as the FKBP-ligand FK506 enhances BMP activity in various cell...
Autores principales: | Quist-Løkken, Ingrid, Andersson-Rusch, Clara, Kastnes, Martin Haugrud, Kolos, Jürgen Markus, Jatzlau, Jerome, Hella, Hanne, Olsen, Oddrun Elise, Sundan, Anders, Knaus, Petra, Hausch, Felix, Holien, Toril |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885706/ https://www.ncbi.nlm.nih.gov/pubmed/36717825 http://dx.doi.org/10.1186/s12964-022-01033-9 |
Ejemplares similares
-
Picomolar FKBP inhibitors enabled by a single water-displacing methyl group in bicyclic [4.3.1] aza-amides
por: Kolos, Jürgen M., et al.
Publicado: (2021) -
High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells
por: Andersson-Rusch, Clara, et al.
Publicado: (2023) -
MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2015) -
Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2018) -
TGF-β contamination of purified recombinant GDF15
por: Olsen, Oddrun Elise, et al.
Publicado: (2017)